Supplementary Methods

Perforin and granzyme B staining
Cryopreserved cells isolated from TET tissues were thawed and 5 × 10 4 cells were co-cultured with 1 × 10 4 U251 cells and 100 ng/ml of EphA2/CD3 BiTE per well. In the evaluation of T-cell cytotoxicity enhanced by nivolumab, 1 g/ml of nivolumab (provided by Ono Pharmaceutical) was added to plates with 100 ng/ml of EphA2/CD3 BiTE. As a control, 1 g/ml of human IgG4 (Abcam) was added to plates with 100 ng/ml of EphA2/CD3 BiTE. After a 48-hour co-culture, harvested cells were washed and stained with antibodies against surface antigens and fixable viability dye (eBioscience) at 4 C for 30 minutes. After the incubation, cells were washed, fixed, and permeabilized with Cytofix/Cytoperm solution (BD Bioscience) at 4 C for 30 minutes. Perforin and granzyme were then stained with antibodies for perforin (clone B-D48; Biolegend) and granzyme B (clone GB11; Biolegend), followed by FACS analyses.
PD-L1 staining
The rabbit monoclonal anti-human PD-L1 antibody used was clone E1L3N (Cell Signaling). Heat-induced epitope retrieval with High pH Target Retrieval Solution (DAKO) was performed. Endogenous peroxidase activity was blocked by incubating in 0.01M phosphate-buffered saline containing 0.3% hydrogen peroxidase and 0.1% sodium azide, and the EnVision plus system (DAKO) was used for secondary detection.
The final product was visualized by 3-3' diaminobenzidine. Gating strategy of the FACS analysis for intracellular cytokine staining.
The gating strategy of intracellular cytokine staining was shown using BD LSRFortessa with FACSDiva software.
